Release date: September 2008 Expiration date: September 30, 2009 Estimated time to complete activity: 45 minutes Sponsored by Curatio CME Institute Support for this activity has been provided through an educational grant from Genentech, Inc. Activity Overview A 45-year-old male patient with a 15-year history of recalcitrant psoriasis presents to your virtual office, and you—in consultation with Jeffrey M. Weinberg, MD, of St. Luke's-Roosevelt Hospital Center and Beth Israel Medical Center in New York—are providing his care. Among the issues that arise over the course of this case are the safety and efficacy of combination therapy with biologics (eg, etanercept, efalizumab) and traditional systemic therapy agents (eg, methotrexate), monitoring for such adverse events as thrombocytopenia and hemolytic anemia, and the management of transient mild breakthrough and generalized inflammatory flare. This activity follows the progression of this case over several months, solicits your clinical input on key aspects of the case, and presents treatment recommendations provided from other clinicians who have “consulted” on this case. Target Audience This activity has been designed to meet the educational needs of dermatologists, dermatology residents and fellows, and other health care professionals involved in the care of patients with psoriasis. Learning Objectives Upon completion of this activity, participants should be able to: - Describe issues that result in difficult-to-treat cases
- Discuss treatment strategies, such as combination therapy and transitioning agents
- Evaluate how clinical data impacts daily dermatology practice
Faculty Jeffrey M. Weinberg, MD Department of Dermatology St. Luke's-Roosevelt Hospital Center Beth Israel Medical Center New York, New York
Accreditation Statement Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Curatio CME Institute designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Method of Participation There are no fees for participating in this CME activity. To receive credit during the period September 2008 to September 30, 2009, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section. Media The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience. Disclosure In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below: Jeffrey M. Weinberg, MD has disclosed the following relevant financial relationships: | Speaker | Abbott, Amgen, Genentech | Curatio CME Institute Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships. Lauren Showers, Program Manager, has disclosed no relevant financial relationships. Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships. Disclaimer The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition. Unapproved Product Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Genentech, Inc. do not recommend the use of any agent outside the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute and Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Hardware/Software Requirements - Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher
- If you are using a Mac computer system and are experiencing problems with your browser, we suggest downloading the latest version of Firefox for Mac
- Javascript-enabled browser
- High-speed Internet connection
- Adobe Flash Player plugin v.8.0+
Contact Information PsoriasisTx.com 100 Campbell Boulevard Suite 103 Exton, PA 19341 editor@curatiocme.com Policy on Privacy and Confidentiality Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx.com users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME. Curatio CME Institute does not require individuals to register to use PsoriasisTx.com; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.com. Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced. Information gathered through PsoriasisTx.com will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed. Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx.com is used. This information helps Curatio CME Institute determine the best strategies for improving PsoriasisTx.com and better meeting the needs of its users. This software does not identify individual users. PsoriasisTx.com does not employ cookies or any other software that violates a user's privacy. If you have any questions about PsoriasisTx.com or any Curatio CME Institute policies, you may contact us at editor@psoriasistx.com. Thank you for using PsoriasisTx.com.
|